Janux Therapeutics, Inc.（JANX）宣布与百时美施贵宝（Bristol Myers Squibb）签署战略合作协议及全球独家授权协议，双方将聚焦于开发针对实体瘤的创新肿瘤激活疗法。该合作标志着两家公司在肿瘤治疗领域的深度协同，有望为实体瘤患者带来突破性治疗方案。
Janux Therapeutics, Inc.（JANX）宣布与百时美施贵宝（Bristol Myers Squibb）签署战略合作协议及全球独家授权协议，双方将聚焦于开发针对实体瘤的创新肿瘤激活疗法。该合作标志着两家公司在肿瘤治疗领域的深度协同，有望为实体瘤患者带来突破性治疗方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.